Published in Virol J on October 03, 2011
Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource. Hepatology (2014) 4.15
Recombination in hepatitis C virus. Viruses (2011) 1.05
Phylogeography, risk factors and genetic history of hepatitis C virus in Gabon, central Africa. PLoS One (2012) 1.02
Hepatitis C virus genetic variability and evolution. World J Hepatol (2015) 0.96
Whole genome pyrosequencing of rare hepatitis C virus genotypes enhances subtype classification and identification of naturally occurring drug resistance variants. J Infect Dis (2012) 0.94
Characterization of Hepatitis C Virus Recombination in Cameroon by Use of Nonspecific Next-Generation Sequencing. J Clin Microbiol (2015) 0.81
Characterization of hepatitis C virus genotypes by direct sequencing of HCV 5'UTR region of isolates from Saudi Arabia. PLoS One (2014) 0.78
Multiple sequence alignment with the Clustal series of programs. Nucleic Acids Res (2003) 38.75
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature (2009) 26.47
Phylogeny.fr: robust phylogenetic analysis for the non-specialist. Nucleic Acids Res (2008) 19.09
Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol (1999) 18.82
Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N Engl J Med (1998) 14.40
Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology (2005) 9.39
The global burden of hepatitis C. Liver Int (2009) 8.89
Telaprevir for previously treated chronic HCV infection. N Engl J Med (2010) 8.33
Telaprevir and pegylated interferon-alpha-2a inhibit wild-type and resistant genotype 1 hepatitis C virus replication in patients. Hepatology (2007) 6.12
Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. N Engl J Med (1996) 4.61
The Los Alamos hepatitis C sequence database. Bioinformatics (2004) 3.67
Is an "a la carte" combination interferon alfa-2b plus ribavirin regimen possible for the first line treatment in patients with chronic hepatitis C? The ALGOVIRC Project Group. Hepatology (2000) 3.42
A natural intergenotypic recombinant of hepatitis C virus identified in St. Petersburg. J Virol (2002) 3.20
euHCVdb: the European hepatitis C virus database. Nucleic Acids Res (2006) 2.41
National Institutes of Health Consensus Development Conference: management of hepatitis C: 2002. Hepatology (2002) 2.19
Identification of a naturally occurring recombinant genotype 2/6 hepatitis C virus. J Virol (2006) 1.90
Hepatitis C virus genotyping: interrogation of the 5' untranslated region cannot accurately distinguish genotypes 1a and 1b. J Clin Microbiol (2002) 1.78
Nomenclature and numbering of the hepatitis C virus. Methods Mol Biol (2009) 1.75
Comparison of hepatitis C virus NS5b and 5' noncoding gene sequencing methods in a multicenter study. J Clin Microbiol (2005) 1.45
New natural intergenotypic (2/5) recombinant of hepatitis C virus. J Virol (2007) 1.34
Full-length open reading frame of a recombinant hepatitis C virus strain from St Petersburg: proposed mechanism for its formation. J Gen Virol (2004) 1.31
Evidence for separation of HCV subtype 1a into two distinct clades. J Viral Hepat (2010) 1.26
A natural inter-genotypic (2b/1b) recombinant of hepatitis C virus in the Philippines. J Med Virol (2006) 1.21
Serendipitous identification of natural intergenotypic recombinants of hepatitis C in Ireland. Virol J (2006) 1.20
Evidence of recombination in intrapatient populations of hepatitis C virus. PLoS One (2008) 1.16
Use of the MagNA pure LC automated nucleic acid extraction system followed by real-time reverse transcription-PCR for ultrasensitive quantitation of hepatitis C virus RNA. J Clin Microbiol (2004) 1.16
Genetic characterization of hepatitis C virus strains in Estonia: fluctuations in the predominating subtype with time. J Med Virol (2007) 1.10
Molecular epidemiology of HCV genotypes among injection drug users in Taiwan: Full-length sequences of two new subtype 6w strains and a recombinant form_2b6w. J Med Virol (2010) 1.04
Molecular epidemiology and interferon susceptibility of the natural recombinant hepatitis C virus strain RF1_2k/1b. J Infect Dis (2008) 0.97
Comparative analysis of hepatitis C virus phylogenies from coding and non-coding regions: the 5' untranslated region (UTR) fails to classify subtypes. Virol J (2006) 0.95
Primer sequence modification enhances hepatitis C virus genotype coverage. J Clin Microbiol (2005) 0.90
Hepatitis C virus superinfection of liver grafts: a detailed analysis of early exclusion of non-dominant virus strains. J Gen Virol (2010) 0.90
Natural intragenotypic and intergenotypic HCV recombinants are rare in southwest China even among patients with multiple exposures. J Clin Virol (2010) 0.82
Mamu-B*08-positive macaques control simian immunodeficiency virus replication. J Virol (2007) 3.61
Sensitivity of hepatitis C virus to cyclosporine A depends on nonstructural proteins NS5A and NS5B. Hepatology (2007) 2.70
A dominant role for CD8+-T-lymphocyte selection in simian immunodeficiency virus sequence variation. J Virol (2004) 2.33
Molecular typing of major histocompatibility complex class I alleles in the Indian rhesus macaque which restrict SIV CD8+ T cell epitopes. Immunogenetics (2007) 2.14
Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study. Blood (2008) 2.00
Comparison of hepatitis C virus treatment between incarcerated and community patients. Hepatology (2012) 1.47
Vitamin D and the anti-viral state. J Clin Virol (2011) 1.40
Addition of ceftaroline to daptomycin after emergence of daptomycin-nonsusceptible Staphylococcus aureus during therapy improves antibacterial activity. Antimicrob Agents Chemother (2012) 1.40
Cyclosporine inhibits a direct interaction between cyclophilins and hepatitis C NS5A. PLoS One (2010) 1.29
Analysis of hepatitis C virus intrahost diversity across the coding region by ultradeep pyrosequencing. J Virol (2012) 1.29
The high frequency Indian rhesus macaque MHC class I molecule, Mamu-B*01, does not appear to be involved in CD8+ T lymphocyte responses to SIVmac239. J Immunol (2005) 1.17
Phosphorylation of yellow fever virus NS5 alters methyltransferase activity. Virology (2008) 1.13
Milkers' nodules complicated by erythema multiforme and graft-versus-host disease after allogeneic hematopoietic stem cell transplantation for multiple myeloma. Clin Infect Dis (2005) 1.10
Selection of an optimal RNA transfection reagent and comparison to electroporation for the delivery of viral RNA. J Virol Methods (2007) 0.91
Protein kinase G phosphorylates mosquito-borne flavivirus NS5. J Virol (2009) 0.90
The flaviviral methyltransferase is a substrate of Casein Kinase 1. Virus Res (2009) 0.86
Phosphorylation events during viral infections provide potential therapeutic targets. Rev Med Virol (2011) 0.86
Phenotypic analysis of NS5A variant from liver transplant patient with increased cyclosporine susceptibility. Virology (2013) 0.83
Pharmacological disruption of hepatitis C NS5A protein intra- and intermolecular conformations. J Gen Virol (2013) 0.82
Subtype specific differences in NS5A domain II reveals involvement of proline at position 310 in cyclosporine susceptibility of hepatitis C virus. Viruses (2012) 0.81
Mosquito protein kinase G phosphorylates flavivirus NS5 and alters flight behavior in Aedes aegypti and Anopheles gambiae. Vector Borne Zoonotic Dis (2013) 0.80
Thiopurines inhibit bovine viral diarrhea virus production in a thiopurine methyltransferase-dependent manner. J Gen Virol (2008) 0.79
West Nile virus methyltransferase domain interacts with protein kinase G. Virol J (2013) 0.79
Telaprevir to boceprevir switch highlights lack of cross-reactivity. Clin Infect Dis (2012) 0.78
Fluorescence resonance energy transfer-based intracellular assay for the conformation of hepatitis C virus drug target NS5A. J Virol (2012) 0.78
A thiopurine drug inhibits West Nile virus production in cell culture, but not in mice. PLoS One (2011) 0.77
Clearance duration as a predictor of sustained viral response in patients with chronic hepatitis C virus genotype 1. J Infect Dis (2005) 0.75
High-risk human papillomavirus DNA detected in primary squamous cell carcinoma of urinary bladder. Arch Pathol Lab Med (2013) 0.75